CorMedix Inc.
CRMD
$6.38
$0.010.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.09% | 447.52% | -3.95% | 53.32% | 584.89% |
| Total Depreciation and Amortization | 175.26% | 2,226.89% | 0.62% | 20.91% | 73.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 170.49% | -2,160.65% | -23.58% | 159.03% | 8.25% |
| Change in Net Operating Assets | 217.91% | -451.83% | 257.95% | 77.57% | -68.50% |
| Cash from Operations | 206.13% | 2.88% | 51.96% | 451.50% | 58.86% |
| Capital Expenditure | -240.08% | -2,016.32% | -134.31% | -0.99% | -3.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.48% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.62% | 195.04% | -10,835.97% | 37.15% | -104.64% |
| Cash from Investing | 101.13% | -1,341.34% | -10,275.67% | 35.90% | -104.81% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | -182.11% | -- | -- | -- | -- |
| Issuance of Common Stock | 248.17% | -98.41% | 1,073.94% | -37.28% | -19.44% |
| Repurchase of Common Stock | 44.54% | -87.52% | 75.71% | -1,808.24% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,895.61% | -- | -- | -- | -- |
| Cash from Financing | -100.94% | 80.83% | 1,266.22% | -46.01% | -19.82% |
| Foreign Exchange rate Adjustments | -533.33% | -62.50% | 300.00% | 113.33% | -475.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.64% | -218.18% | 262.88% | 377.82% | -20.47% |